Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease.
about
Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and ProgressionOcular indicators of Alzheimer's: exploring disease in the retinaFLIMX: A Software Package to Determine and Analyze the Fluorescence Lifetime in Time-Resolved Fluorescence Data from the Human Eye.Spectral Domain-Optical Coherence Tomography As a New Diagnostic Marker for Idiopathic Normal Pressure Hydrocephalus.Combination of confocal principle and aperture stop separation improves suppression of crystalline lens fluorescence in an eye model.Noise-Corrected Principal Component Analysis of fluorescence lifetime imaging data.The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington DiseaseVisual system manifestations of Alzheimer's disease.Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.Can the retina be used to diagnose and plot the progression of Alzheimer's disease?Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy - a novel approach.Quantitative Live Cell FLIM Imaging in Three Dimensions.Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy.Characterization of NAD(P)H and FAD autofluorescence signatures in a Langendorff isolated-perfused rat heart modelUsefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease
P2860
Q26752621-98C2E8A0-7F81-4CA9-A678-8D37B133CD59Q28078670-D2A0D2CB-1DCD-4686-AB8A-CCC753EB9382Q30981602-7043CABE-9927-4C6F-8271-AC05A8B07981Q33619411-DA769358-A51E-445A-96FD-2D3744E6F1F3Q36152294-37334456-CEDD-47B4-A444-D554191E6216Q36220545-00764130-6811-4CE9-8515-4631FC09ED49Q37319246-53562D83-AA49-41B4-8EC8-A1C47F6D2EE5Q39013852-4486F9EC-BF45-47D3-8CD2-F078F67BC9D3Q39091275-2A155465-E0FF-4D98-AB23-4619801BCEAEQ47315641-47249040-CFB9-4F3D-A951-A8E8C1441209Q47378999-90099ED0-CF21-4A42-BED8-4D79763E1320Q47698217-142CF4D0-95DF-4F9B-8F54-AA7728C18021Q51126092-2FE081C3-10DD-4869-B27B-AC2C8EE1AAF4Q57492608-F3F551E8-F06E-43BA-A652-46D623BA9191Q58612352-83723701-A172-4EF0-A142-B5D7F25616F0
P2860
Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@ast
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@en
type
label
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@ast
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@en
prefLabel
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@ast
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@en
P2093
P2860
P356
P1433
P1476
Retinal fluorescence lifetime ...... verity of Alzheimer's disease.
@en
P2093
Dietrich Schweitzer
Jens Dawczynski
Kai-Uwe Schmidtke
Karl-Jürgen Bär
Martin Hammer
Susanne Jentsch
Sven Peters
P2860
P304
P356
10.1111/AOS.12609
P577
2014-12-07T00:00:00Z